Site Pain Common with COVID-19 Vaccine, but It Improves in 3 Days: Safety Follow-Up

Pfizer/BioNTech’s COVID-19 vaccine carries a high incidence of pain at the injection site, with over 90% of recipients experiencing this reaction, which improves in three days, an interim report on a Japanese cohort study has revealed. The cohort study, led...read more